Amylyx Pharmaceuticals is a startup based in the United States, 3 tracked investors.
Based in the United States, Amylyx Pharmaceuticals is a startup founded in 2013. Brouky records 3 investors associated with the company.
Amylyx Pharmaceuticals develops therapies for neurodegenerative diseases, focusing on treatments that address ALS and other related disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.